0
0.5
1
1.5
2+
Mortality
-18%
Improvement
Relative Risk
Mortality (b)
1%
Mortality (c)
-130%
Mortality (d)
-9%
Mortality (e)
-90%
Mortality (f)
-16%
Ventilation
-29%
HCQ for COVID-19 Stewart et al. LATE TREATMENT
Is late treatment with HCQ beneficial for COVID-19?
Retrospective 2,399 patients in the USA
Higher mortality (p=0.27) and ventilation (p=0.093), not sig.
c19hcq.org
Stewart et al., PLoS ONE, March 2021
Favors HCQ
Favors control